This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Peking University, Shanghai Institutes for Biological Sciences, Cas. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010
Title: Zhuan Zhou: Innovator in Receptor-Ligand Binding Detection
Introduction
Zhuan Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biological sciences, particularly in the area of receptor-ligand binding detection. His innovative methods have the potential to advance research in cellular biology and drug development.
Latest Patents
Zhuan Zhou holds a patent for a "Method for screening the receptor-ligand binding in live cell." This invention relates to methods and systems for detecting ligand binding to membrane receptors and endocytosis. The method involves incubating a cell with a dye and a ligand, followed by detecting dye-containing endocytic vesicles within the cell. The system for screening ligand binding includes an automatic liquid handling device, an x-y stage for positioning a plate, a microscope for imaging endocytic vesicles, software for automatic analysis of FM spots, and a control unit for managing the movement of the x-y stage and the microscope.
Career Highlights
Zhuan Zhou has worked at several prestigious institutions, including the Shanghai Institutes for Biological Sciences, CAS, and Peking University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Hoping Cheng and Heping Cheng. Their collaborative efforts have further enhanced the impact of Zhuan Zhou's work in receptor-ligand binding detection.
Conclusion
Zhuan Zhou's innovative methods for detecting receptor-ligand binding represent a significant advancement in biological research. His contributions have the potential to facilitate new discoveries in cellular biology and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile